Verdiva Bio
77 employees on LinkedIn · 4 known investors
Find your way into Verdiva Bio
Sign up to see every warm intro you have to Verdiva Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Verdiva Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.
Founders & leadership
Investors · 4
How we know: a partner's Signal profile · generalatlantic.com · Not right? Tell us
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements$410M disclosed across 1 round · 2025
- $410MSeries AJan 2025 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Verdiva Bio do?
- Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.
- Who are Verdiva Bio's investors?
- Verdiva Bio's investors include General Atlantic, OrbiMed, RA Capital, Forbion.
- How much funding has Verdiva Bio raised?
- Verdiva Bio has disclosed $410M raised across 1 round.





